Westbourne is Now an Approved ValGenesis Partner

We are delighted to announce that we are now a ValGenesis partner. ValGenesis is the developer of a suite of digital validation and process lifecycle management tools used by pharmaceutical companies across the globe.

John O’Sullivan, Westbourne Founder and CEO, welcomed the new partnership.

John said: “Working with companies in the pharmaceutical industry as closely as we do at Westbourne, it is clear to see the digitalisation and process optimisation benefits of the ValGenesis suite of products.

“We were equally impressed in our discussions with the ValGenesis team of the company’s innovative approach, and its push to continuously develop its products to meet the evolving needs of the pharma industry and further enhance compliance, productivity, and management oversight.

“This new partnership between Westbourne and ValGenesis combines the industry-leading features of the ValGenesis software suite and the extensive pharmaceutical IT and technology expertise of Westbourne. Together, we can help companies accelerate digital transformation, respond to challenges in the market, streamline compliance, and improve profitability.”

ValGenesis Software Range

The applications and platforms from ValGenesis are tried and tested in the pharmaceutical industry. The company also has an extensive global footprint of users.

The ValGenesis software range is split into two main groupings:

• Validation Lifecycle Suite
• Process Lifecycle Suite

Validation Lifecycle Suite

• iVAL – end-to-end digital validation platform.
• iClean – digitalised cleaning validation platform.
• iOps – digitalised operation execution platform.

Process Lifecycle Suite

• iCMC – digitalised and centralised process and analytical development platform for all CMC stages.
• iCPV – digitalised and centralised continued process verification platform.

Experience and Expertise at Westbourne

Westbourne is particularly well placed to be a ValGenesis partner because of our extensive experience delivering IT, validation, and technology-related solutions to the pharmaceutical industry. Our knowledge and expertise extend across both technical and scientific areas, and we invest heavily in cross-skilling members of our team to enhance the scientific skills of technical staff and the technical skills of scientific staff.

Bo Olsen, SVP of Partners at ValGenesis, said: “At ValGenesis, we want to partner with companies aligned with our values and that have expertise and knowledge that is valued by our customers in the life sciences sector. Westbourne easily meets these requirements.

“We are excited to add Westbourne as an approved ValGenesis partner, and we look forward to working with the team as we help our common customers digitalise their operations.”

Supporting Your Digital Validation Journey

Westbourne validation specialist, Mayank Sharma, also welcomed the new partnership.

Mayank said: “Over the last number of weeks, I have been going deeper into the ValGenesis range of digital validation software products. I can see now more than ever the benefits to companies in the pharmaceutical industry. Streamlining compliance, eliminating manual data entry, eliminating human error, and enhancing automation are all objectives that are possible with software from ValGenesis.”

Westbourne digital transformation specialist, David Tucker, said: “Digital transformation project success depends on expertise, effective planning, and robust, right-fit technology platforms. With our integration and configuration capabilities, and ongoing support from our team at Westbourne, you can take the next step on your digital transformation and digital validation journey, with software from ValGenesis providing a robust foundation to build on for the future.”

To find out more about the ValGenesis software range and how to implement the software in your facility, please contact us at Westbourne today.

Subscribe to our latest insights